Company intelligence / Profile preview

Integrated Medical Development

Princeton, New Jersey, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Integrated Medical Development (IMD) is a specialized clinical development and medical communications consultancy that provides strategic support to pharmaceutical and biotechnology companies. The firm offers a range of services including clinical trial design, regulatory strategy, medical affairs support, and data dissemination. In June 2022, IMD was acquired by The Lockwood Group, a leading medical communications agency, to bolster its scientific and clinical capabilities. IMD is recognized for its ability to bridge the gap between clinical research and commercialization, helping clients translate complex data into impactful medical narratives.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Integrated Medical Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrated Medical Development.

Explore the full profile